Indicated for: prevention and treatment of thromboembolism
Route of administration: injectable
Substance: heparin (anticoagulant)
ATC: B01AB01 (Blood and blood forming organs | Antithrombotic agents | Heparin group)
Dose adjustment may be needed in kidney disease.
This medicine may have important interactions with other medicines.
This medicine is subject to additional monitoring.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
This medicine may increase the risk of bleeding.
Heparin is an anticoagulant used for the prevention and treatment of deep vein thrombosis, pulmonary embolism, and other thromboembolic conditions. It works by inhibiting blood clot formation.
The medication is administered subcutaneously or intravenously, as directed by a doctor. It is important to monitor coagulation parameters during treatment.
Side effects may include bleeding, injection site reactions, or, in rare cases, heparin-induced thrombocytopenia.
Heparin is not recommended for patients with hypersensitivity to this medication, severe coagulation disorders, or active bleeding.
NHP 10 (C2) - Replacement of renal function in patients with chronic renal failure
Price
Copayment
Patient
44.70 RON
44.70 RON
0.00 RON